Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology ...Middle East

PR Newswire - News
Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology
Investment led by Esperante Ventures and Ferring Ventures: Additional funding to support expanded SPT-2101 clinical trial. Progress with SPT-2101 for Meniere's Disease: Encouraging data from the Australian clinical trial validates Spiral's proprietary drug delivery platform, with plans to...

Read More Details
Finally We wish PressBee provided you with enough information of ( Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology )

Apple Storegoogle play

Also on site :